← FDA DRUG APPROVALS

FDA NDA · NDA019786

LOPRESSOR

Sponsor: NOVARTIS

APPLICATION
NDA019786
TYPE
NDA
ORIGINAL APPROVAL
1989-12-27
LATEST ACTION
1989-12-27
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

LOPRESSORDiscontinued
METOPROLOL FUMARATE EQ 300MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
LOPRESSORDiscontinued
METOPROLOL FUMARATE EQ 100MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
LOPRESSORDiscontinued
METOPROLOL FUMARATE EQ 400MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
LOPRESSORDiscontinued
METOPROLOL FUMARATE EQ 200MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL

Approval history

1989-12-27Type 2 - New Active Ingredient and Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →